Top Header Mobile

Updates

Contact

 Speaker Profile

img-Yang_Pan

Ph.D., Executive Director, Gilead Sciences

Yang Pan

Biography
 Dr. Yang Pan leads clinical oncology biomarker development and translational efforts at Gilead Sciences. The focus of her research includes applying biomarkers (pharmacodynamic, predictive, prognostic and safety biomarkers) in all phases of clinical trials. Using conventional and innovative biomarker platforms from both tumor biopsies and noninvasive samples, the aims of Dr. Pan’s team are to inform dosing, understand mechanism of action and resistance in targeted patient populations. Prior to Gilead Dr. Pan was a Director of Medical Sciences at Amgen. Dr. Pan received her Ph.D. in Biochemistry from the University of California, San Diego and MBA from University of Washington Business School.


 Session Abstract – PMWC 2023 Silicon Valley

img-Jan. 26 - Track 4: Clinical Utility of Liquid Biopsies Track

Jan. 26 - Track 4: Clinical Utility of Liquid Biopsies Track
Track 4 - January 26 9.00 A.M.-4.30 P.M.


Track Chair: Cindy Perettie, Roche

  • PMWC 2023 Award Ceremony
    - Luis Alberto Diaz Jr., MSK
    - Razelle Kurzrock, Medical College of Wisconsin
  • Non-invasive Liquid Biopsy Techniques (PANEL)
    Chair: Razelle Kurzrock, Medical College of Wisconsin
    - Apostolia Tsimberidou, MD Anderson
    - Mandana Kamgar, MD Medical College of Wisconsin
    - Mina Nikanjam, UCSD
    - Ash Alizadeh, Stanford University
  • Liquid Biopsy Challenges and Limitations (PANEL)
    Chair: Victor Lin, Mary Bird Perkins
    - Luis Alberto Diaz Jr., MSK
    - Maximilian Diehn, Stanford
    - Dana Dilbeck, Agilent
    - Emma Shtivelman, Cancer Commons
  • Liquid Biopsy in Clinical Trials: Learnings and COVID Experience (PANEL)
    Chair: Cindy Perettie, Roche Diagnostics
    - Eric Peters, Genenetch
    - Andrew Mckenzie, Sarah Cannon
    - Yang Pan, Gilead
    - Alan Sandler, Mirati Therapeutics
  • Multi-Cancer Early Detection Through Multi-Biomarker Class Liquid Biopsy Testing
    Chair: Tom Beer, Exact Sceinces
  • Liquid Biopsy for Early Cancer Detection (PANEL)
    Chair: Priti Hegde, Foundation Medicine
    - Daniel Kim, UCSC
    - Mike Nolan, Freenome
    - Jeffrey Venstrom, Grail Bio
    - Kathryn Phillips, UCSF
    - Lon Castle, eviCore healthcare
    - Tom Beer, Exact Sciences
  • Liquid Biopsy for Minimal Residual Disease (PANEL)
    Chair: Minetta Liu, Natera
    - Peter Bach, Delfi diagnostics
    - Laura Vantveer, UCSF
    - Susan Bobulsky, Adaptive
    - Joshua Cohen, Johns Hopkins
  • PMWC Showcase
    - Harmeet Dhani, Biological Dynamics
    - Varsha Rao, Claret Bio
  • PMWC NCI Showcase
    - Xianghong Jasmine Zhou, EarlyDiagnostics